172 related articles for article (PubMed ID: 27605421)
21. miR-122-5p as a plasma biomarker of liver injury in fish exposed to microcystin-LR.
Florczyk M; Brzuzan P; Krom J; Woźny M; Łakomiak A
J Fish Dis; 2016 Jun; 39(6):741-51. PubMed ID: 26345281
[TBL] [Abstract][Full Text] [Related]
22. Identification of serum miRNAs by nano-quantum dots microarray as diagnostic biomarkers for early detection of non-small cell lung cancer.
Fan L; Qi H; Teng J; Su B; Chen H; Wang C; Xia Q
Tumour Biol; 2016 Jun; 37(6):7777-84. PubMed ID: 26695145
[TBL] [Abstract][Full Text] [Related]
23. Identification of Specific MicroRNA Biomarkers in Early Stages of Hepatocellular Injury, Cholestasis, and Steatosis in Rats.
Kagawa T; Shirai Y; Oda S; Yokoi T
Toxicol Sci; 2018 Nov; 166(1):228-239. PubMed ID: 30125006
[TBL] [Abstract][Full Text] [Related]
24. Dysregulated Serum MicroRNA Expression Profile and Potential Biomarkers in Hepatitis C Virus-infected Patients.
Zhang S; Ouyang X; Jiang X; Gu D; Lin Y; Kong SK; Xie W
Int J Med Sci; 2015; 12(7):590-8. PubMed ID: 26283876
[TBL] [Abstract][Full Text] [Related]
25. Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure.
Vegter EL; Ovchinnikova ES; Silljé HHW; Meems LMG; van der Pol A; van der Velde AR; Berezikov E; Voors AA; de Boer RA; van der Meer P
PLoS One; 2017; 12(5):e0177242. PubMed ID: 28475616
[TBL] [Abstract][Full Text] [Related]
26. Identification and validation of reference genes for the detection of serum microRNAs by reverse transcription-quantitative polymerase chain reaction in patients with bladder cancer.
Wang L; Liu Y; Du L; Li J; Jiang X; Zheng G; Qu A; Wang H; Wang L; Zhang X; Liu H; Pan H; Yang Y; Wang C
Mol Med Rep; 2015 Jul; 12(1):615-22. PubMed ID: 25738263
[TBL] [Abstract][Full Text] [Related]
27. miR-208a as a biomarker of isoproterenol-induced cardiac injury in Sod2+/- and C57BL/6J wild-type mice.
Liu L; Aguirre SA; Evering WE; Hirakawa BP; May JR; Palacio K; Wang J; Zhang Y; Stevens GJ
Toxicol Pathol; 2014 Oct; 42(7):1117-29. PubMed ID: 24713317
[TBL] [Abstract][Full Text] [Related]
28. Identification of urinary microRNA biomarkers for detection of gentamicin-induced acute kidney injury in rats.
Zhou X; Qu Z; Zhu C; Lin Z; Huo Y; Wang X; Wang J; Li B
Regul Toxicol Pharmacol; 2016 Jul; 78():78-84. PubMed ID: 27074385
[TBL] [Abstract][Full Text] [Related]
29. Expression of BKV and JCV encoded microRNA in human cerebrospinal fluid, plasma and urine.
Pietilä T; Nummi M; Auvinen P; Mannonen L; Auvinen E
J Clin Virol; 2015 Apr; 65():1-5. PubMed ID: 25766978
[TBL] [Abstract][Full Text] [Related]
30. Identification of Circulating miRNAs Differentially Regulated by Opioid Treatment.
Toyama K; Kiyosawa N; Watanabe K; Ishizuka H
Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28926935
[TBL] [Abstract][Full Text] [Related]
31. Circulating microRNAs and sudden cardiac arrest outcomes.
Wander PL; Enquobahrie DA; Pritchard CC; McKnight B; Rice K; Christiansen M; Lemaitre RN; Rea T; Siscovick D; Sotoodehnia N
Resuscitation; 2016 Sep; 106():96-101. PubMed ID: 27423422
[TBL] [Abstract][Full Text] [Related]
32. Identification of suitable plasma-based reference genes for miRNAome analysis of major depressive disorder.
Liu X; Zhang L; Cheng K; Wang X; Ren G; Xie P
J Affect Disord; 2014 Jul; 163():133-9. PubMed ID: 24479999
[TBL] [Abstract][Full Text] [Related]
33. Identification of a plasma four-microRNA panel as potential noninvasive biomarker for osteosarcoma.
Lian F; Cui Y; Zhou C; Gao K; Wu L
PLoS One; 2015; 10(3):e0121499. PubMed ID: 25775010
[TBL] [Abstract][Full Text] [Related]
34. Plasma miR-208 as a useful biomarker for drug-induced cardiotoxicity in rats.
Nishimura Y; Kondo C; Morikawa Y; Tonomura Y; Torii M; Yamate J; Uehara T
J Appl Toxicol; 2015 Feb; 35(2):173-80. PubMed ID: 25092230
[TBL] [Abstract][Full Text] [Related]
35. microRNA expression profile in human coronary smooth muscle cell-derived microparticles is a source of biomarkers.
de Gonzalo-Calvo D; Cenarro A; Civeira F; Llorente-Cortes V
Clin Investig Arterioscler; 2016; 28(4):167-77. PubMed ID: 27363781
[TBL] [Abstract][Full Text] [Related]
36. Variability in microRNA recovery from plasma: Comparison of five commercial kits.
Brunet-Vega A; Pericay C; Quílez ME; Ramírez-Lázaro MJ; Calvet X; Lario S
Anal Biochem; 2015 Nov; 488():28-35. PubMed ID: 26271186
[TBL] [Abstract][Full Text] [Related]
37. Comprehensive Analysis of Circulating microRNA Specific to the Liver, Heart, and Skeletal Muscle of Cynomolgus Monkeys.
Iguchi T; Niino N; Tamai S; Sakurai K; Mori K
Int J Toxicol; 2017; 36(3):220-228. PubMed ID: 28460582
[TBL] [Abstract][Full Text] [Related]
38. A comparison between quantitative PCR and droplet digital PCR technologies for circulating microRNA quantification in human lung cancer.
Campomenosi P; Gini E; Noonan DM; Poli A; D'Antona P; Rotolo N; Dominioni L; Imperatori A
BMC Biotechnol; 2016 Aug; 16(1):60. PubMed ID: 27538962
[TBL] [Abstract][Full Text] [Related]
39. A serum exosomal microRNA panel as a potential biomarker test for gastric cancer.
Wang N; Wang L; Yang Y; Gong L; Xiao B; Liu X
Biochem Biophys Res Commun; 2017 Nov; 493(3):1322-1328. PubMed ID: 28986250
[TBL] [Abstract][Full Text] [Related]
40. Circulating miRNAs as Biomarkers of Acute Muscle Damage in Rats.
Siracusa J; Koulmann N; Bourdon S; Goriot ME; Banzet S
Am J Pathol; 2016 May; 186(5):1313-27. PubMed ID: 26952641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
